Nan Fung Group Holdings Ltd

CIK 0001782539 · Q2 2026

13F Equity AUM

$131.5M

+8.4% QoQ

Positions

+1 QoQ

AUM Rank

#7,519

Top 86%

Skill Alpha (FF)

-0.3%/yr^ns

No Clear Edge

Rank #3,169 · Top 38%

vs S&P -12.2%/yr (unadj.)

Quarters Tracked

~5 years

Portfolio Concentration

Top 5: 66.2%Top 10: 82.4%Top 20: 98.7%

MPLT26.5%

LBRX15.6%

EVMN14.6%

HELP5.0%

INCY4.6%

RYTM4.2%

ONC3.4%

OCSAW3.2%

ASCENDIS PHARMA A/S2.8%

RVMD2.7%

Others (15)17.6%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare91.2%

Unclassified5.9%

Other2.8%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 25Median: 2.25%Avg: 4.00%

0–0.5%

6(1.8%)

0.5–1%

2(1.3%)

1–3%

9(20.0%)

3–5%

5(20.3%)

5%+

3(56.6%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 25vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New2Increased1Decreased2Exited1

New Positions

ASCENDIS PHARMA A/S2.8%

+14K

CHYM0.3%

+21K

Increased

HELP5.0%

+527K(+115%)

Decreased

OCSAW3.2%

-50,180(-14%)

BOLT0.0%

-24,250(-83%)

Exited

ASND

-13,600

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...